Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Neoplasms 1 Neoplasm Metastasis 1 Gastrointestinal Neoplasms 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × encorafenib × Clear all

NCT05097378 2021-10-28

PREMIUM

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Unknown

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡